News

ThromboGenics re-files ocriplasmin BLA and Inspiration submits IB 1001 to FDA

17-04-2012

Belgian biopharma company ThromboGenics NV (Euronext Brussels: THR) said this morning that it has resubmitted…

BiotechnologyInspiration BiopharmaceuticalsIpsenNorth AmericaocriplasminOphthalmicsPharmaceuticalRegulationThromboGenics

COMPANY SPOTLIGHT

Menarini

Back to top